Physician Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Physician Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.03K	Hold	1,669	–	–	﹤0.01%	972
2026 Q1	$5.86K	Hold	1,669	–	–	﹤0.01%	952
2025 Q4	$5.63K	Hold	1,669	–	–	﹤0.01%	944
2025 Q3	$2.19K	Hold	1,669	–	–	﹤0.01%	1185
2025 Q2	$1.2K	Buy	+1,669	New	+$1.31K	﹤0.01%	1277

Other funds holding IRWD

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Physician Wealth Advisors's IRWD Position: Q2 2026 in Review

Physician Wealth Advisors held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 1,669 shares worth $7.03K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Physician Wealth Advisors first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Physician Wealth Advisors held 1,669 shares of Ironwood Pharmaceuticals worth $7.03K as of Q2 2026.
Physician Wealth Advisors left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #972 holding.
Physician Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
45 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.